Oncology & Cancer

Nanotech'ed RNA drug reduces ovarian cancer tumors by 83 percent

By loading fragile RNA into silicon nanoparticles, researchers from The Methodist Hospital and two other institutions found a new drug delivery system can reduce the size of ovarian tumors by as much as 83 percent—and stop ...

Oncology & Cancer

Cancer registry improves understanding of rare ovarian tumor

Ovarian granulosa cell tumors are a rare type of ovarian cancer that affect the ovaries and fallopian tubes, and can extend further into the pelvis and lymph nodes. Treatment typically follows the same guidelines as other ...

Oncology & Cancer

Genes behind aggressive endometrial cancer found

In a major breakthrough for uterine serous carcinoma (USC)—a chemo-resistant, aggressive form of endometrial cancer, Yale researchers have defined the genetic landscape of USC tumors, findings that point to new treatment ...

Health

Keep beauty regimen safe during pregnancy, doctor advises

(HealthDay)—For the many pregnant women who are concerned about how beauty products, such as hair dyes and skin creams, will affect their developing baby, an expert offers some advice on what is safe.

Obstetrics & gynaecology

Blood test detects Down syndrome during pregnancy

(HealthDay) -- A second company reports that it has developed a prenatal blood test to detect Down syndrome, potentially providing yet another option for pregnant women who want to know whether their unborn child has the ...

Obstetrics & gynaecology

Vaginal delivery as safe as cesarean for most early preterm births

Vaginal delivery for early preterm fetuses presenting head first, or vertex presentation, had a high rate of success with no difference in neonatal mortality compared to cesarean delivery, a new study published in the American ...

page 10 from 34